Merit Financial Group, LLC Amgen Inc Transaction History

Merit Financial Group, LLC

  • $4.59 Billion
  • Q3 2024

A detailed history of Merit Financial Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Merit Financial Group, LLC holds 14,196 shares of AMGN stock, worth $3.98 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
14,196
Previous 18,560 23.51%
Holding current value
$3.98 Million
Previous $5.8 Million 21.12%
% of portfolio
0.1%
Previous 0.12%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024
SELL
$309.38 - $337.38 $1.35 Million - $1.47 Million
-4,364 Reduced 23.51%
14,196 $4.57 Million
Q2 2024

Aug 13, 2024
BUY
$262.75 - $319.31 $106,939 - $129,959
407 Added 2.24%
18,560 $5.8 Million
Q1 2024

May 06, 2024
BUY
$268.87 - $324.56 $2.41 Million - $2.91 Million
8,952 Added 97.29%
18,153 $5.16 Million
Q4 2023

Feb 06, 2024
SELL
$255.7 - $288.46 $309,652 - $349,325
-1,211 Reduced 11.63%
9,201 $2.65 Million
Q3 2023

Nov 07, 2023
BUY
$218.65 - $271.46 $614,187 - $762,531
2,809 Added 36.95%
10,412 $2.8 Million
Q2 2023

Aug 01, 2023
BUY
$214.27 - $253.37 $350,331 - $414,259
1,635 Added 27.4%
7,603 $1.69 Million
Q1 2023

Apr 24, 2023
BUY
$225.79 - $275.2 $279,302 - $340,422
1,237 Added 26.15%
5,968 $1.44 Million
Q4 2022

Jan 13, 2023
BUY
$229.03 - $291.01 $94,589 - $120,187
413 Added 9.56%
4,731 $0
Q3 2022

Oct 31, 2022
SELL
$224.46 - $253.15 $337,138 - $380,231
-1,502 Reduced 25.81%
4,318 $973,000
Q2 2022

Aug 08, 2022
BUY
$230.71 - $256.74 $812,791 - $904,495
3,523 Added 153.37%
5,820 $1.42 Million
Q1 2022

May 13, 2022
BUY
$219.27 - $242.57 $141,867 - $156,942
647 Added 39.21%
2,297 $555,000
Q4 2021

Feb 14, 2022
SELL
$198.88 - $227.6 $27,843 - $31,864
-140 Reduced 7.82%
1,650 $371,000
Q3 2021

Oct 27, 2021
SELL
$212.27 - $248.7 $15,707 - $18,403
-74 Reduced 3.97%
1,790 $381,000
Q2 2021

Aug 16, 2021
SELL
$233.58 - $259.14 $61,197 - $67,894
-262 Reduced 12.32%
1,864 $454,000
Q1 2021

May 18, 2021
BUY
$221.91 - $258.6 $47,932 - $55,857
216 Added 11.31%
2,126 $529,000
Q4 2020

Feb 12, 2021
SELL
$216.38 - $257.67 $15,795 - $18,809
-73 Reduced 3.68%
1,910 $439,000
Q3 2020

Nov 10, 2020
BUY
$234.65 - $260.95 $38,951 - $43,317
166 Added 9.14%
1,983 $504,000
Q2 2020

Aug 13, 2020
SELL
$197.81 - $242.74 $7,714 - $9,466
-39 Reduced 2.1%
1,817 $428,000
Q1 2020

May 05, 2020
BUY
$182.24 - $241.7 $10,752 - $14,260
59 Added 3.28%
1,856 $376,000
Q4 2019

Jan 16, 2020
BUY
$189.21 - $243.2 $340,010 - $437,030
1,797 New
1,797 $433,000

Others Institutions Holding AMGN

# of Institutions
3,123
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Merit Financial Group, LLC Portfolio

Follow Merit Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Merit Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merit Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email